|
|
Other links at Articles > Cardiology |
| 1. |
First Data on Aliskiren in Diabetic Nephropathy
|
|
|
The first trial of the new direct renin inhibitor, aliskiren, in patients with diabetic nephropathy shows that it reduces proteinuria when added to conventional treatment. But observers say this is merely a surrogate-end-point trial and definitive guidance on how to use this drug in such patients will come only from an ongoing large outcomes study, ALTITUDE. Heartwire
|
| 2. |
New Euro Survey Finds HF Management Poor Among GPs, Internists
|
|
|
A new Europe-wide survey has found wide differences among physician specialties and countries in terms of how they diagnose and treat heart failure. The results reinforce the need for better education of all those involved in HF and indicate how important a multidisciplinary approach is, say the researchers. Heartwire
|
| 5. |
Clevidipine in the ER: A New Option for Severe, Acute Hypertension?
|
|
|
Results of a new trial with clevidipine, an investigational calcium-channel blocker with an ultrashort half-life of less than one minute, show the drug has promise in patients presenting to the emergency room with an acute severe episode of hypertension. Heartwire
|
|
|
